The North American kyphoplasty market was estimated at US$538.1M in 2016 across the three markets (Canada, Mexico, and the US) covered in this report. By the end of the forecast period in 2023, it is estimated that market will grow to approximately US$1.1B at a Compound Annual Growth Rate (CAGR) of 11.1%.
The US represented the largest portion of the market in 2016, holding more than 90.0% of the regional revenue, and is expected to maintain this dominance through the forecast period. Mexico is expected to be the fastest-growing market through 2023, at a CAGR of 12.6%, while the slowest growth will be observed in the US at a CAGR of 11.0%.
The market for VCF repair products, including kyphoplasty balloons and kits, is a highly consolidated market. Together, three orthopedic conglomerates-DePuy Synthes, Medtronic, and Stryker-dominated the global market in 2016. These companies hold well-established orthopedic portfolios and enjoy wide-ranging distribution networks, which allow them to effectively cross-sell their VCF products. Several minor players also operate in regional markets, and domestic manufacturers of cheap copycat products are a threat in developing countries.
Key drivers of the kyphoplasty market in the forecast period are:
– The rising prevalence of osteoporosis and osteopenia due to the increasing aging population.
– The increasing preference for minimally invasive and outpatient procedures.
Key Topics Covered:
1. About the Authors
2. Table of Contents
3. Executive Summary
5. Market Outlook
6. Market Insights
7. Competitive Assessment
– DePuy Synthes (Johnson & Johnson)
– Globus Medical